Company / Return on Equity (ROE)
Bruker Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-0.4%
FY2025
5-year range
-0.4% / 31.0%
FY2021-FY2025
Trend
-105.5%
vs FY2024
Sector context
#88 of 147
Health Care
What the data says
Bruker reports negative total equity of -0.4% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-0.4% in FY2025 with a 5-year CAGR of -16.8%.
Declined from 31.0% to -0.4% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -27.0pp
- 5-Year Change
- -16.8pp
- 10-Year Change
- -
Sector benchmark
#88 of 147 in Health CareTop 60% of 147This company -0.4% Sector average -3.0%
▼
+88.5% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 105.5% year-over-year.
- Currently 2.7pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2023.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -0.4% | -105.5% |
| FY2024 | 6.3% | -79.5% |
| FY2023 | 31.0% | +16.5% |
| FY2022 | 26.6% | +2.9% |
| FY2021 | 25.9% | +57.7% |
| FY2020 | 16.4% | -24.5% |
| FY2019 | 21.8% | +8.5% |
| FY2018 | 20.0% | +84.9% |
| FY2017 | 10.8% | -51.6% |
| FY2016 | 22.4% | +60.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026